Funding for this research was provided by:
Fonds de Recherche du Québec - Santé
Gouvernement du Canada | Canadian Institutes of Health Research (102630, MOP 102630, 324876)
Foundation for the National Institutes of Health (2R01 GM066099, 5R01 GM079656)
Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (311997)
Received: 22 June 2018
Accepted: 6 August 2019
First Online: 9 September 2019
Change Date: 16 April 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
: M.B., C.L., and G.P. have a patent on BRET biosensors licensed to Domain Therapeutics North America and Pfizer Inc. The remaining authors declare no competing interests.